VASC Vascular Solutions, Inc.

NEW YORK, Nov. 19, 2014 /PRNewswire/ -- Securities lawyers at Dunnam & Dunnam are investigating allegations for Vascular Solutions Inc. shareholders (NASDAQ:VASC). Concerned VASC investors who purchased between June 28, 2011 and November 13, 2014 are encouraged to contact securities attorney Hamilton Lindley by clicking here.

The law firm's investigation will focus on the fact that an indictment has been brought against Vascular Solutions Inc. The indictment alleges that Vascular Solutions and its CEO introduced adulterated and misbranded medical devices into interstate commerce, and conspired to introduce adulterated and misbranded medical devices into interstate commerce. When news of the indictment broke, Vascular Solutions' stock fell 11%.

Dunnam & Dunnam has significant experience representing shareholders in securities lawsuits nationwide. VASC stockholders – or anyone with knowledge about this situation – should contact lawyer Hamilton Lindley at hlindley@dunnamlaw.com with questions or concerns toll free at 844-702-2990 or visit http://www.dunnamlaw.com/VASC.  

SOURCE Dunnam & Dunnam